Orchestra BioMed (OBIO) officer has shares withheld for RSU tax payment

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. insider Joshua Aiello, the Principal Accounting Officer, reported a small share disposition tied to taxes, not a market trade. The company withheld 241 shares of Common Stock at $4.57 per share to cover tax obligations from restricted stock unit vesting. After this withholding, Aiello directly holds 18,644 shares of Common Stock.

Insider Trade Summary

Net Seller: 241 shares

Net Sell 1 txn

Insider Aiello Joshua

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, par value $0.0001 per share ("Common Stock")	241	$4.57	$1K

Holdings After Transaction: Common Stock, par value $0.0001 per share ("Common Stock") — 18,644 shares (Direct)

Footnotes (1)

1. F1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

FAQ

What did Orchestra BioMed (OBIO) insider Joshua Aiello report in this Form 4?

Joshua Aiello reported a small share disposition related to tax withholding, not an open-market trade. The issuer withheld 241 shares to satisfy taxes on vested RSUs, and Aiello now directly holds 18,644 Common Stock shares after the transaction.

Was the Orchestra BioMed (OBIO) Form 4 transaction a market sale of shares?

No, the transaction was not a market sale. The 241 shares were withheld by the issuer to cover tax obligations from restricted stock unit vesting, and the footnote explicitly states that no shares were sold in the market as a result.

How many Orchestra BioMed (OBIO) shares were involved in the tax withholding event?

The event involved 241 shares of Common Stock, withheld at $4.57 per share to satisfy tax obligations on vested RSUs. This is a relatively small number of shares compared with Aiello’s remaining direct ownership position reported after the transaction.

What is Joshua Aiello’s Orchestra BioMed (OBIO) shareholding after this Form 4 transaction?

Following the tax-related withholding, Joshua Aiello directly holds 18,644 shares of Orchestra BioMed Common Stock. This post-transaction figure reflects his remaining direct ownership after 241 shares were withheld by the issuer to meet RSU-related tax obligations.

What does the transaction code “F” mean in the Orchestra BioMed (OBIO) Form 4?

Code “F” indicates a tax-withholding disposition, where shares are delivered to the issuer to cover tax liabilities or exercise costs. In this case, 241 shares were withheld to pay taxes on RSU vesting, and no open-market sale occurred according to the footnote.

Does this Orchestra BioMed (OBIO) insider filing indicate a change in insider sentiment?

The filing mainly reflects a routine tax-withholding event, not a discretionary buy or sell decision. Since the 241 shares were withheld to cover RSU-related taxes and no market sale occurred, it provides limited insight into Aiello’s view of the company’s stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/27/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aiello Joshua

(Last) (First) (Middle)

C/O ORCHESTRA BIOMED HOLDINGS, INC.

150 UNION SQUARE DRIVE

(Street)

NEW HOPE PENNSYLVANIA 18938

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share ("Common Stock")	03/25/2026		F(1)		241	D	$4.57	18,644	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

	/s/ Andrew Taylor, Attorney-in-Fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)